| SPADIN |
H-TYR-ALA-PRO-LEU-PRO-ARG-TRP-SER-GLY-PRO-ILE-GLY-VAL-SER-TRP-GLY-LEU-ARG-OH |
1270083-24-3 |
| Mcl1-IN-1 |
2-[2-[(5-氯-8-羟基-7-喹啉基)(2-吡啶基氨基)甲基]苯氧基]乙酸 |
713492-66-1 |
| TSI-01 |
TSI-01 |
704878-75-1 |
| TC-S 7005 |
TC-S 7005 |
1082739-92-1 |
| AT-7519 trifluoroacetate |
4-[(2,6-二氯苯甲酰基)氨基]-N-4-哌啶基-1H-吡唑-3-甲酰胺三氟乙酸盐 |
1431697-85-6 |
| AM 114 |
AM 114 |
856849-35-9 |
| K145 |
1309444-75-4 |
1309444-75-4 |
| Acetic acid, 2-[4-[[4-(2-chlorophenyl)-2-thiazolyl]methoxy]-2-methylphenoxy]- |
2-[4-[[4-(2-氯苯基)-2-噻唑基]甲氧基]-2-甲基苯氧基]乙酸 |
1050506-75-6 |
| RSC 133 |
RSC 133 |
1418131-46-0 |
| 5-(4-BroMophenyl)-3-(1,2-dihydro-6-Methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-Pyrazole-1-butanoic Acid |
5-(4-BROMOPHENYL)-3-(1,2-DIHYDRO-6-METHYL-2-OXO-4-PHENYL-3-QUINOLINYL)-4,5-DIHYDRO-G-OXO-1H-PYRAZOLE-1-BUTANOIC ACID |
380560-89-4 |
| ASP-VAL-VAL-ASP-ALA-ASP-GLU-TYR-LEU-ILE-PRO-GLN |
EGF RECEPTOR (985-996) (HUMAN) |
96249-43-3 |
| BMN 673 (8R,9S) |
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氢-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-00-5 |
| TRX818 |
TRX818 |
1256037-58-7 |
| FIIN-2 |
FIIN-2 |
1633044-56-0 |
| ML 351 |
ML 351 |
847163-28-4 |
| [(3R)-3-Amino-4-[(3-hexylphenyl)amino]-4-oxobutyl]-phosphonic acid mono(trifluoroacetate) |
[(3R)-3-氨基-4-[(3-己基苯基)氨基]-4-氧代丁基]-膦酸单(三氟乙酸盐) |
909725-62-8 |
| GSK-3 inhibitor 1 |
3-(9-氟-1,2,3,4-四氢吡咯并[3,2,1-JK][1,4]苯并二氮杂卓-7-基)-4-咪唑并[1,2-A]吡啶-3-基-1H-吡咯-2,5-二酮单盐酸盐 |
603272-51-1 |
| OTS514 |
OTS514 |
1338540-55-8 |
| CRANAD 28 |
CRANAD 28 |
1623747-97-6 |
| (E)-2-((1,4-dimethylpiperazin-2-ylidene)-amino)-5-nitro-N-phenylbenzamide(WXC09160) |
(E)-2-((1,4-二甲基哌嗪-2-亚基)氨基)-5-硝基-N-苯基苯甲酰胺 |
1613465-33-0 |
